Hudson Bay Capital Management LP Pharvaris N.V. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$21.26 - $32.07 $1.07 Million - $1.61 Million
-50,116 Reduced 71.46%
20,018 $462,000
Q4 2023

Feb 14, 2024
BUY
$15.2 - $28.05 $474,863 - $876,310
31,241 Added 80.33%
70,134 $1.97 Million
Q3 2023

Nov 14, 2023
BUY
$14.68 - $21.4 $570,949 - $832,310
38,893 New
38,893 $811,000

Others Institutions Holding PHVS

# of Institutions
51
Shares Held
39.6M
Call Options Held
0
Put Options Held
0
View Full List

About Pharvaris N.V.

PHVS Quotes by TradingView
  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $625M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email